SGHT Q1 2025 Earnings — Sight Sciences, Inc. Revenue & Financial Results | Market Cap Arena

SGHTSight Sciences, Inc.

$224M

Q1 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$18M-9.1% YoY

Gross Profit

$15M86.2% margin

Operating Income

-$14M-79.2% margin

Net Income

-$14M-80.8% margin

EPS (Diluted)

$-0.28

QoQ Revenue Growth

-8.2%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$12M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$130M

Total Liabilities

$52M

Stockholders' Equity

$78M

Cash & Equivalents

$109M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$18M	$19M	-9.1%
Gross Profit	$15M	$16M	-8.4%
Operating Income	-$14M	-$15M	+5.9%
Net Income	-$14M	-$16M	+13.0%

Revenue Segments

Surgical Glaucoma

$17M98%

Dry Eye

$394,0002%